StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

N1-Methyl-2-pyridone-5-carboxamide

HCID 69698
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
701-44-0
Standard-SMILES
Cn1cc(C(N)=O)ccc1=O
InChIKey
JLQSXXWTCJPCBC-UHFFFAOYSA-N
Summenformel
C7H8N2O2
Durchschnittliche Molmasse
152,15 g/mol
Monoisotopische Masse
152,0585775

Überblick

N-methyl-6-pyridone-3-carboxamide is a pyridone that is 2-pyridone substituted with a carboxamide group at C-5 and a methyl group at N-1. It has a role as a metabolite and a mouse metabolite. It is a member of methylpyridines, a pyridinecarboxamide and a pyridone.

Namen und Bezeichner

Bevorzugter Name
N1-Methyl-2-pyridone-5-carboxamide
IUPAC
1-methyl-6-oxopyridine-3-carboxamide
Englischer Name
1-methyl-6-oxo-pyridine-3-carboxamide
Summenformel
C7H8N2O2
Molmasse
152.15

Namen und Synonyme

Nudifloramide701-44-01-methyl-6-oxo-1,6-dihydropyridine-3-carboxamideN1-Methyl-2-pyridone-5-carboxamideN'-Methyl-2-pyridone-5-carboxamide1-Methyl-5-carboxylamide-2-pyridone3-Pyridinecarboxamide, 1,6-dihydro-1-methyl-6-oxo-DTXSID7022037468139USC7WN(1)-methyl-2-pyridone-5-carboxamideRefChem:831461DTXCID70142865
Weitere Namen anzeigen
2-PyN-methyl-6-pyridone-3-carboxamide1-Methyl-6-oxo-1,6-dihydronicotinamideNicotinamide Impurity 6(Nedifloramide)1-Methyl 6-oxo-1,6-dihydro-3-pyridinecarboxamide
1-methyl-6-oxopyridine-3-carboxamideN-methyl-2-pyridone-5-carboxamideMFCD004572831-METHYL-6-OXO-PYRIDINE-3-CARBOXAMIDE2PY3-Carbamoyl-1-methyl-6-pyridoneN-Me-2PY1,6-Dihydro-1-methyl-6-oxonicotinamide

Datenbank-Bezeichner

CAS
701-44-0

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-1
Polarare Oberfläche (TPSA)
63,4 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
1
Schwere Atome
11
Formalladung
0
Komplexität
266

Experimentelle und physikochemische Eigenschaften

Physical DescriptionSolid
Collision Cross Section132.1 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

Physikochemische Eigenschaften

Schmelzpunkt
202 · 202-207°C (dec.)
Siedepunkt
396.7 · 396.7±42.0 °C(Predicted)
Dichte
1.3 · 1.300±0.06 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
Löslichkeit
DMSO (Slightly), Methanol (Slightly, Heated)
Aggregatzustand
Solid
pka
14.46 · 14.46±0.20(Predicted)
Farbe
White to Light Brown
InChI
1S/C7H8N2O2/c1-9-4-5(7(8)11)2-3-6(9)10/h2-4H,1H3,(H2,8,11)
InChIKey
JLQSXXWTCJPCBC-UHFFFAOYSA-N

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P260, P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Toxikologische Informationen

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 Eintrag

Uremic toxins such as N-methyl-2-pyridone-5-carboxamide are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.
Tissue LocationsPlacenta
Cellular LocationsCytoplasm
Metabolite PathwaysNicotinate and nicotinamide metabolism

Verwendung und Herstellung

UsesNaturally produced by the body (endogenous).
Anwendungen · 1 Eintrag

BeschreibungNudifloramide, known more commonly as N-methyl-2-pyridone-5-carboxamide (2-Py), is a metabolite of niacin via nicotinamide. It can be measured in serum and urine as part of metabolomic studies of niacin or nicotinamide intake and usage. Circulating levels of nudifloramide can be elevated and associated with toxic effects in patients receiving supplemental nicotinamide.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid ethyl esterMethanolAmmoniak, wasserfrei

Ergänzende Hinweise

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
PubChem CID
69698
DTXSID
DTXSID70220374
ChEMBL
CHEMBL3542314
ChEBI
CHEBI:27410
UNII
68139USC7W
EC Number
977-620-1
Nikkaji
J121.846H
SMILES
[n]1([c](ccc(c1)C(=O)N)=O)C
Signs and Symptoms · 1 Eintrag

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Sicherheitsdaten

wgk
WGK 3
hs_code
2933399090
Speicherklasse
11 - Combustible Solids

DefinitionChEBI: A pyridone that is 2-pyridone substituted with a carboxamide group at C-5 and a methyl group at N-1.